Protocol of Determining the Effect of Selenium Supplementation on CD4 + T Lymphocyte Count in HIV/AIDS Patients: A Randomized Double Blind Placebo Controlled Trial

Journals Menu

Follow SCIRP

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.org/journal/aid
E-mail: aid@scirp.org

"Protocol of Determining the Effect of Selenium Supplementation on CD4 + T Lymphocyte Count in HIV/AIDS Patients: A Randomized Double Blind Placebo Controlled Trial"
written by Sahar Yousefi, Azar Hadadi, Afshin Ostovar, Behnaz Edalat Noor, Mehrnaz Rasoolinejad, Mahboobeh Haji Abdolbaghi, Hossien Khalili,
published by Advances in Infectious Diseases, Vol.1 No.2, 2011

has been cited by the following article(s):

[1]	The effect of selenium and zinc on CD4 (+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial
	2019

[2]	Protocol of Determining the Effect of Vimang® and Spirel® Supplementation in Aids Patients with Delayed Diagnosis of HIV: An Open Randomized Controlled …
	2016

[3]	Protocol of Determining the Effect of Vimang® and Spirel® Supplementation in Aids Patients with Delayed Diagnosis of HIV: An Open Randomized Controlled Trial
	Journal of AIDS & Clinical Research, 2016

[4]	Усложнения на антиретровирусната терапия при ХИВ-позитивни пациенти
	2015

[5]	Oxidative stress associated to disease progression and toxicity during antiretroviral therapy in human immunodeficiency virus infection
	Journal of Virology and Microbiology, 2013

[6]	Physical activity as antioxidant and palliative beneficial option in human immunodeficiency virus infection
	Oxidants and Antioxidants in Medical Science, 2013

[7]	ANTIRETROVIRAL TOXICITY AND OXIDATIVE STRESS
	American Journal of Pharmacology and Toxicology, 2013

Follow SCIRP

[1]	The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial Acta Clinica Belgica, 2019 DOI:10.1080/17843286.2019.1590023